Cellectis S.A.
CLLS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $163,019 | $175,599 | $95,662 | $363,941 |
| - Cash | $143,251 | $136,708 | $89,789 | $185,636 |
| + Debt | $91,461 | $85,056 | $75,771 | $100,871 |
| Enterprise Value | $111,229 | $123,947 | $81,644 | $279,176 |
| Revenue | $41,506 | $755 | $19,171 | $30,346 |
| % Growth | 5,397.5% | -96.1% | -36.8% | – |
| Gross Profit | $32,324 | -$6,664 | $10,687 | $28,502 |
| % Margin | 77.9% | -882.6% | 55.7% | 93.9% |
| EBITDA | -$9,462 | -$92,637 | -$76,378 | -$78,425 |
| % Margin | -22.8% | -12,269.8% | -398.4% | -258.4% |
| Net Income | -$36,761 | -$101,059 | -$106,139 | -$114,197 |
| % Margin | -88.6% | -13,385.3% | -553.6% | -376.3% |
| EPS Diluted | -0.41 | -1.77 | -2.33 | -1.93 |
| % Growth | 76.8% | 24% | -20.7% | – |
| Operating Cash Flow | $22,103 | -$24,746 | -$87,444 | -$104,562 |
| Capital Expenditures | -$2,578 | -$1,073 | -$2,441 | -$18,556 |
| Free Cash Flow | $19,524 | -$25,819 | -$89,885 | -$123,118 |